Countermovement jump peak force discriminates low hip bone mineral density in postmenopausal women Authors: Raphael Gonçalves de Oliveira, Mariana Machado Signoreti, Larissa Victória Branco, Andreo Fernando Aguiar, Laís Campos de Oliveira Published: 2026 ABSTRACT AbstractPostmenopausal women are at increased risk of low bone mineral density (BMD) and osteoporotic fractures, yet access to dual-energy X-ray absorptiometry (DXA) remains limited in many settings. This study evaluated the diagnostic accuracy of countermovement jump (CMJ)-derived variables for identifying low BMD in postmenopausal women. In this diagnostic accuracy study, 123 postmenopausal women underwent DXA assessment at the lumbar spine and total hip and performed CMJ testing on a force plate to obtain jump height, peak force, and peak power. Receiver operating characteristic analyses were used to assess accuracy. Overall, 21.1% of participants had low BMD. CMJ variables showed low accuracy for the lumbar spine and when sites were analyzed jointly (AUC < 0.70). In contrast, peak force (AUC = 0.78) and peak power (AUC = 0.72) demonstrated moderate accuracy for identifying low total hip BMD. A cutoff ≤ 1101.1 N for peak force yielded 66.7% sensitivity and 91.2% specificity. After adjustment for age and years since menopause, only peak force remained significantly associated with low hip BMD (OR = 17.6; p = 0.001). These findings suggest that CMJ-derived peak force may serve as a preliminary screening tool to identify postmenopausal women at risk of low hip BMD, however, the proposed cutoff is exploratory and requires external validation before clinical implementation.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-54419-x.Keywords: Physical fitness, Musculoskeletal fitness, Osteoporosis, Bone mineral densitySubject terms: Diseases, Endocrinology, Health care, Medical research Introduction Postmenopausal women experience a range of adverse health effects, primarily due to the hormonal changes associated with menopause, including marked reductions in estrogen and androgen levels1. A major physiological consequence is the accelerated decline in bone mineral density (BMD), which may lead to osteopenia and, subsequently, osteoporosis — conditions that markedly increase the risk of fractures and their complications, such as hospitalization and, in severe cases, even death2,3. Notably, one in three women over the age of 50 will sustain an osteoporotic fracture during the remainder of their lifetime4,5. Therefore, prevention has become the most effective strategy to minimize the occurrence of these events. Assessing bone mineral density (BMD) through dual-energy X-ray absorptiometry (DXA), the gold-standard method for this purpose, is essential6. For instance, in postmenopausal women, each standard deviation (SD) decrease in femoral neck BMD is associated with a two- to threefold increase in fracture risk7. However, in many regions, DXA assessments are not routinely performed, even among at-risk populations, primarily because of high costs and limited access, particularly in Latin American countries such as Argentina, Brazil, Colombia, and Mexico (Argentina, Brazil, Colombia and Mexico)8,9. In these settings, access to BMD testing remains extremely restricted due to the low availability of DXA equipment, which is mainly concentrated in private clinics and large urban centers8. Thus, using alternative, more accessible, and low-cost tools represents a feasible option for initial screening and can be implemented on a large scale, including outside clinical or hospital settings. Once individuals at higher risk are identified, they can be referred for more accurate assessments, such as DXA, to confirm low BMD10. The clinical prediction of low BMD in postmenopausal women is typically based on questionnaires. However, although these instruments generally show high sensitivity (ability to identify true positives), they tend to have low specificity (ability to identify true negatives) for predicting low BMD in this population11,12. A test that has shown potential for identifying individuals with low BMD and that can also serve as a complementary assessment is the countermovement jump (CMJ)13–15. This test assesses lower-limb muscle strength and power, both of which have been recognized as key determinants of bone mass and geometry16–19. Maximal muscle contractions and rapid accelerations of the body, as occur during the CMJ, impose substantial mechanical loads on the skeleton, thereby stimulating increases in bone strength19. An additional advantage is that the CMJ can easily be incorporated into physical fitness assessments — comprehensive test batteries that evaluate multiple components of physical performance. In this context, criterion values (previously established cutoff points for discriminating low BMD) may serve as training targets to be achieved over time, for example, following exercise interventions20. In simple terms, the CMJ involves performing a maximal vertical jump from an upright position, generating propulsion through a rapid countermovement, a semi-squat action that engages the stretch-shortening cycle via muscle spindle activation, thereby potentiating subsequent force and power production21. This test has gained attention because it is quick to perform, induces minimal fatigue, and requires little familiarization22. Previous studies have shown that CMJ peak power has the potential to discriminate low BMD in younger populations13–15. Baptista et al.13 and Janz et al.14 reported moderate accuracy of CMJ peak power for identifying low BMD in children and adolescents, respectively, whereas King15 observed similar accuracy in young adults. In older adults, although no accuracy studies have been conducted, CMJ peak force has been shown to be strongly associated with total bone area, while peak power was strongly associated with total hip BMD17. The most commonly analyzed CMJ variable is jump height; however, other parameters, such as peak force and peak power derived from ground reaction forces measured using a force plate, provide more direct indicators of neuromuscular performance23,24. Although the cost of force plate is substantially lower than that of bone densitometry devices, their availability may still be limited in many applied settings. Field-based approaches, including smartphone applications, can facilitate CMJ assessment by providing valid estimates of jump height25. However, these tools typically provide estimates of mean force and mean power rather than peak values, and their validity for assessing peak force and peak power remains unclear. As a result, the use of these key CMJ-derived metrics in non-laboratory environments is currently limited. In this context, establishing the diagnostic value of force plate-derived peak force and peak power represents an important step toward the future development of valid and feasible field-based screening strategies. However, to date, no accuracy study has evaluated the ability of CMJ-derived variables to discriminate low BMD in postmenopausal women, a population at particularly high risk for developing osteoporosis. Therefore, the present study aimed to determine the diagnostic accuracy of CMJ-derived variables for identifying postmenopausal women with low BMD. We hypothesized that CMJ-derived peak force and peak power would demonstrate at least moderate diagnostic accuracy for identifying low BMD in the total hip region, based on the established role of lower-limb mechanical loading in skeletal adaptation and evidence from prior studies in younger populations. Results Initially, 127 participants met the inclusion criteria and underwent the reference standard test (DXA). However, four participants (3.1%) were unable to perform the index test (CMJ) due to apprehension or fear of executing the movement. No adverse events occurred during testing. Based on the lowest T-score between the lumbar spine and total hip combined, 21.1% of participants were classified as having low BMD (T-score ≤ − 2.0). When analyzed separately, 18.7% and 7.3% of participants presented low BMD in the lumbar spine and total hip, respectively. Table 1 presents the performance values for CMJ variables, comparing postmenopausal women with T-scores > − 2.0 versus ≤ − 2.0 for the lumbar spine and total hip regions, analyzed jointly and separately. When the lumbar spine and total hip were considered together, participants with low BMD (T-score ≤ − 2.0) exhibited significantly lower peak force, whereas no significant differences were observed for jump height or peak power. For the lumbar spine region alone, no significant differences were found between women with T-scores > − 2.0 and those ≤ − 2.0 for any CMJ variable. However, when the total hip region was analyzed separately, participants with low BMD demonstrated significantly lower peak force and peak power compared with those with normal BMD, with no difference observed for jump height. Table 1Performance in countermovement jump variables according to T-score values (> or ≤ − 2.0) for the lumbar spine and total hip regions.CMJ variableLumbar spine and total hipLumbar spineTotal hipT score > −2.0 (n = 97)T score ≤ −2.0 (n = 26)T score > −2.0 (n = 100)T score ≤ −2.0 (n = 23)T score > −2.0 (n = 114)T score ≤ −2.0 (n = 9)JH (cm)7.7 (2.8)7.8 (2.5)7.6 (2.9)8.0 (2.2)7.8 (2.7)6.6 (3.0)PF (N)1493.8 (292.4)1323.5 (338.4)†1477.6 (304.3)1371.8 (322.5)1481.8 (297.1)1152.9 (313.9)†PP (W)1538.9 (420.4)1439.8 (411.2)1520.7 (431.9)1506.2 (364.4)1543.0 (409.6)1201.3 (427.2)†Data are expressed as mean (standard deviation). CMJ: countermovement jump; JH: jump height; PF: peak force; PP: peak power. †Significant difference ( p < 0.05) according to Student’s t-test for independent samples. Performance in countermovement jump variables according to T-score values (> or ≤ − 2.0) for the lumbar spine and total hip regions. Data are expressed as mean (standard deviation). CMJ: countermovement jump; JH: jump height; PF: peak force; PP: peak power. †Significant difference ( p < 0.05) according to Student’s t-test for independent samples. Table 2; Fig. 1 present the diagnostic accuracy of CMJ-derived variables for identifying postmenopausal women with low BMD. When the lumbar spine and total hip regions were analyzed jointly, peak force demonstrated significant accuracy (p = 0.03), although the accuracy was low (AUC < 0.70). For the lumbar spine region alone, none of the CMJ variables showed significant accuracy. In contrast, when the total hip region was considered separately, both peak force and peak power exhibited significant accuracy, with moderate discriminative ability (AUC ≥ 0.70) to identify postmenopausal women with low BMD. Table 2Accuracy of countermovement jump-derived variables for discriminating low bone mineral density in postmenopausal women.VariablesAUC95% CI p Sen (%)Spe (%)Cutoff pointsLumbar spine and total hip (T-score ≤ −2) Jump height0.520.43–0.610.7446.262.9≤ 8.7 cm Peak force0.650.56–0.730.0350.082.5≤ 1188.4 N Peak power0.550.46–0.640.4461.552.6≤ 1462.1 WLumbar spine (T-score ≤ −2) Jump height0.540.45–0.630.4895.720.0≤ 4.7 cm Peak force0.590.50–0.680.2043.580.0≤ 1188.4 N Peak power0.500.41–0.590.9895.713.0≤ 2020.2 WTotal hip (T-score ≤ −2) Jump height0.630.54–0.710.2955.683.3≤ 4.9 cm Peak force0.780.70–0.850.0066.791.2≤ 1101.1 N Peak power0.720.63–0.800.0288.953.5≤ 1458.7 WAUC: area under the curve; 95% CI: 95% confidence interval; Sen: sensitivity; Spe: specificity. Accuracy of countermovement jump-derived variables for discriminating low bone mineral density in postmenopausal women. AUC: area under the curve; 95% CI: 95% confidence interval; Sen: sensitivity; Spe: specificity. Receiver operating characteristic (ROC) curves for countermovement jump-derived variables discriminating low bone mineral density in postmenopausal women. (a–c) Lumbar spine and total hip: (a) jump height, (b) peak force, (c) peak power; (d–f) Lumbar spine: (d) jump height, (e) peak force, (f) peak power; (g–i) Total hip: (g) jump height, (h) peak force, (i) peak power. Therefore, for the total hip region, a cutoff point of ≤ 1101.1 N for peak force provided the best balance between sensitivity and specificity. This threshold correctly identified 66.7% (95% CI: 29.9–92.5%) of true positive cases (women with low BMD who generated values below the cutoff) and 91.2% (95% CI: 84.5–95.7%) of true negative cases (women with normal BMD who generated values above the cutoff). For peak power, the optimal cutoff point (≤ 1458.7 W) yielded sensitivity and specificity values of 88.9% (95% CI: 51.8–99.7%) and 53.5% (95% CI: 43.9–62.9%), respectively. Supplementary Tables 1 and 2 present the criterion values and ROC curve coordinates for the variables that demonstrated moderate accuracy (peak force and peak power) in the CMJ for identifying low BMD in the total hip region. For peak force, the positive and negative likelihood ratios were 7.6 (95% CI: 3.6–16.1) and 0.4 (95% CI: 0.1–0.9), respectively, indicating that a positive index test result (≤ 1101.1 N) was approximately seven and a half times more likely to occur in women with low BMD, while a negative result was more than twice as likely to correctly indicate the absence of low BMD. The corresponding values for peak power were 1.9 (95% CI: 1.4–2.6) and 0.2 (95% CI: 0.0–1.3), respectively. Finally, women with peak force ≤ 1101.1 N had 20-fold higher odds of low total hip BMD (OR = 20.8; 95% CI: 4.5–96.1; p < 0.001), whereas those with peak power ≤ 1458.7 W had approximately ninefold higher odds (OR = 9.2; 95% CI: 1.1–76.0; p = 0.039). After adjustment for age and years since menopause, peak force remained significantly associated with low total hip BMD (OR = 17.6; 95% CI: 3.2–95.4; p = 0.001), whereas peak power was not (OR = 5.5; 95% CI: 0.6–49.1; p = 0.127). Discussion The present study aimed to examine the diagnostic accuracy of countermovement jump (CMJ)-derived variables for identifying low BMD in postmenopausal women. In summary, our findings demonstrated that, among the bone regions analyzed, only the total hip showed acceptable discrimination based on CMJ-derived peak force and peak power, whereas jump height did not demonstrate meaningful discriminatory capacity. Accordingly, for the lumbar spine, either analyzed alone or in combination with the total hip, the diagnostic accuracy of CMJ variables was low (AUC < 0.70). Because the CMJ predominantly depends on lower-limb force and power generation, this may explain why these variables were able to discriminate low BMD in the hip region but not in the lumbar spine. The muscles primarily engaged during the CMJ include the vastus lateralis, vastus intermedius, vastus medialis, plantar flexors, and gluteus maximus26. An advantage of this test over isometric methods is that the CMJ allows a more accurate estimation of maximal muscle force in terms of peak tension, which is considered the main mechanical stimulus driving skeletal adaptation17,27. Previous studies with objectives similar to ours have been conducted exclusively in children13, adolescents14 and young adults15, which limits direct comparisons with the present findings. Nevertheless, these studies provide useful context. For example, Baptista et al.13, reported moderate accuracy of CMJ-derived peak power for identifying low BMD in children (AUC = 0.85 for girls and 0.82 for boys), using values estimated from jump height. Although these findings suggest that CMJ performance may be informative for bone health assessment in younger populations, important methodological and physiological differences must be considered when comparing these results with those observed in postmenopausal women. Similarly, Janz et al.14 reported that CMJ-derived peak power demonstrated moderate to high accuracy for identifying low BMD in adolescents, with AUC values ranging from 0.66 to 0.84 depending on the skeletal site. However, no cutoff values were provided, which limits the clinical applicability of these findings. In young adults, King15 also observed moderate accuracy (AUC = 0.71) for peak power in discriminating low femoral neck BMD, with specific cutoff values reported for men and women. Taken together, these findings suggest that CMJ-derived peak power may be a useful indicator of bone health in younger populations. However, in contrast to the present study, peak power did not remain significantly associated with low BMD after adjustment, indicating that its discriminatory performance may be less consistent in postmenopausal women. Across the studies conducted in younger populations, peak power was consistently selected as the CMJ-derived variable of interest and demonstrated moderate accuracy for identifying low BMD. In contrast, the present study observed moderate diagnostic accuracy for both peak force and peak power in discriminating low total hip BMD, with peak force showing the most consistent performance after adjustment. This difference may be partially explained by variations in population characteristics and assessment protocols, including age-related differences in bone properties and the skeletal sites analyzed. In younger individuals, previous literature has reported strong associations between peak power and BMD, which likely explains its predominant use in earlier studies28,29. However, peak force during dynamic tasks such as the CMJ may more directly reflect the mechanical loading applied to the hip, and has also been shown to correlate with BMD27,30, supporting its relevance as a functional marker in postmenopausal women. It is also worth noting that body mass may be positively associated with both ground reaction forces during jumping and BMD27, as greater mechanical loading from body weight chronically stimulates bone remodeling31. This interplay suggests that body mass may act as a shared determinant of both CMJ performance and bone health in postmenopausal women. Notably, peak force was analyzed in absolute terms in the present study, which may partially reflect the contribution of body mass to ground reaction force generation. Previous evidence supports a significant association between muscle function and bone health across the lifespan. A systematic review with meta-analysis reported moderate to large associations between muscle strength and bone outcomes in younger populations32. In older adults, although peak power has been shown to be independently associated with hip BMD, peak force appears to be more consistently related to structural bone parameters, such as total hip bone area17. These findings suggest that CMJ-derived variables may relate differently to bone outcomes depending on both the skeletal parameter assessed and the characteristics of the population. In this context, peak force measured during dynamic tasks such as the CMJ may provide a more direct estimate of peak muscle tension, which is considered a key mechanical stimulus for skeletal adaptation27. Consistent with this notion, significant associations between peak force and bone mass have been reported across different age groups. In contrast, peak power declines more rapidly with aging33, potentially reflecting age-related neuromuscular changes and comorbidities34, which may limit its stability as a discriminative measure in older populations. This may help explain why, in the present study, peak force demonstrated more consistent discriminatory performance for low hip BMD after adjustment. In the present study, peak force and peak power showed distinct but complementary diagnostic characteristics for identifying low hip BMD. Peak force demonstrated high specificity (91.2%) and a notable positive likelihood ratio (7.6), indicating a strong ability to rule in low BMD when the test is positive. In contrast, peak power exhibited high sensitivity (88.9%) and a lower negative likelihood ratio (0.2), suggesting a greater ability to reduce false-negative results. Although the ideal values for these indicators are above 10.0 and below 0.1, respectively, tests presenting positive likelihood ratios between 5 and 10 or negative likelihood ratios between 0.1 and 0.2 can still provide clinically meaningful information35. However, when considering the overall evidence, peak force emerged as the most consistent and clinically relevant indicator, given its higher discriminative accuracy and stronger likelihood ratio profile. This is further supported by the magnitude of the associations observed in unadjusted analyses, in which women below the cutoff values had substantially higher odds of low hip BMD. In the adjusted models, only peak force remained significantly associated with low hip BMD after controlling for age and years since menopause, reinforcing its role as the most consistent CMJ-derived variable in this context. In contrast, peak power was no longer statistically significant, suggesting that its discriminatory performance may be partially influenced by confounding factors. Although the magnitude of the association for peak force remained high, the wide confidence intervals indicate limited precision of the estimates, likely due to the small number of participants with low BMD in the total hip. Therefore, these findings should be interpreted with caution, and future studies with larger samples are needed to confirm the stability and generalizability of these results. A practical limitation for the implementation of these findings is that peak force, the variable most strongly associated with low hip BMD in the present study, requires force plate instrumentation for direct measurement. Although smartphone-based applications such as My Jump can facilitate CMJ assessment by providing valid estimates of jump height25, they do not allow accurate quantification of peak force. Prediction equations estimating peak power from jump height and body mass have been proposed as field-based alternatives36; however, since peak force, rather than peak power, emerged as the most consistent discriminative variable in the present study, the applicability of such approaches to the proposed screening strategy remains limited. It is worth noting, however, that low-cost force plate alternatives are becoming increasingly available, which may facilitate broader implementation of CMJ-based screening in clinical and community settings. As a result, the application of CMJ-derived peak force as a screening tool may currently be restricted to settings with access to appropriate equipment. Therefore, future studies should aim to develop and validate field-based approaches capable of estimating peak force from easily obtainable variables, thereby enhancing the feasibility and translational potential of CMJ testing in broader clinical and community contexts. Although the present findings support the potential use of CMJ as a practical screening tool for low hip BMD in postmenopausal women, some limitations should be considered. The sample consisted of relatively healthy and functionally independent women, which may explain the high feasibility of CMJ performance observed and may limit the generalizability of the findings to older or more clinically compromised populations. In addition, the mean age of the participants indicates that most were in the early postmenopausal period, and therefore the results may not extend to older or long-lived women. Other limitations include the relatively small number of participants with low BMD in the total hip, which may have contributed to the wide confidence intervals observed in the regression analyses. Furthermore, body composition data were unavailable, as DXA assessments were restricted to the lumbar spine and total hip. Consequently, lean mass and fat mass could not be included as covariates in the adjusted regression models. In addition, although the main CMJ-derived variables were considered, future studies should investigate the diagnostic accuracy and discriminatory performance of additional parameters. As this is the first study to examine the diagnostic accuracy of CMJ-derived variables for identifying low BMD in postmenopausal women, further research in independent and more diverse populations is warranted to confirm the robustness and generalizability of these findings. Finally, the proposed cutoff was both derived and evaluated within the same sample, which increases the risk of overfitting and limits the robustness of the estimates. In conclusion, peak force and peak power derived from the countermovement jump demonstrated moderate accuracy for identifying postmenopausal women with low BMD in the total hip, whereas jump height was not informative. However, only peak force remained independently associated with low hip BMD after adjustment, indicating that it represents the most consistent CMJ-derived indicator for this purpose. These findings support the potential use of CMJ-derived peak force as a complementary, low-cost screening tool to identify women at higher risk of low hip BMD and guide referral for DXA assessment. The proposed cutoff may also serve as a practical reference for monitoring functional performance in response to exercise interventions. This approach is not intended to replace DXA, but to enable large-scale risk stratification in clinical and community settings. Given the cross-sectional design, the limited number of participants with low total hip BMD, and the fact that the cutoff was derived and tested in the same sample, these findings should be considered exploratory. Further studies with larger, independent samples are required to confirm and externally validate these results before clinical implementation. Methods Study design and participants This cross-sectional diagnostic accuracy study was designed to examine whether CMJ-derived variables can identify postmenopausal women with low BMD. The study followed the STARD guidelines37. The dependent variable was BMD, assessed by DXA at the lumbar spine and total hip. These skeletal sites were selected as they are the standard regions recommended for BMD assessment and osteoporosis diagnosis in postmenopausal women according to international clinical guidelines, and are among those most commonly associated with fragility fractures in this population. The independent variables were CMJ performance metrics (jump height, peak force, and peak power) selected for their established association with lower-limb neuromuscular function and mechanical loading on bone. All participants first underwent DXA assessment, followed by standardized CMJ testing on a force plate. Receiver operating characteristic (ROC) analyses were then conducted to determine the accuracy and optimal cutoff points of CMJ-derived variables for identifying low BMD. This study was approved by the Research Ethics Committee for Human Subjects at the Universidade Estadual do Norte do Paraná (opinion 3,493,411). Community-dwelling participants were randomly recruited in the city of Jacarezinho, state of Paraná, Brazil, through advertisements on social media, local radio stations, churches, health units, and flyers distributed in shops and public areas. The inclusion criteria were as follows: (a) age ≥ 50 years; (b) postmenopausal status, defined as the absence of menstruation for at least 12 months; (c) not engaging in systematic physical exercise during the previous six months; (d) ability to perform daily tasks independently; (e) absence of serious cognitive impairment that could hinder the understanding of simple instructions; (f) absence of major dysfunctions or implants in the spine, hip, or lower limbs; (g) absence of neurological disorders or diseases affecting bone metabolism; (h) absence of severe vascular disease, cardiac arrhythmia, pacemaker use, epilepsy, or seizures; (i) absence of retinal disease; (j) absence of severe labyrinthitis or vertigo; (k) no use of medications or supplements intended to increase bone and/or muscle mass within the previous six months; and (l) no cancer treatment within the previous five years. Participants who were unable to perform the CMJ test for any reason were excluded from the final analysis. The sample size was calculated assuming a sensitivity and specificity of 85%, a prevalence of low BMD (osteopenia/osteoporosis) of 40%, a precision of 0.10 as the maximum acceptable error, and a 95% confidence interval38. Based on these parameters, a minimum of 123 participants was required. The final sample therefore consisted of 123 postmenopausal women, with a mean age of 58.8 ± 6.7 years, time since menopause of 10.6 ± 9.4 years, body mass of 73.2 ± 13.1 kg, height of 158.0 ± 5.1 cm, and body mass index of 29.4 ± 5.4 kg/m2. All participants were informed of the benefits and risks of the investigation prior to signing an institutionally approved informed consent document to participate in the study. Procedures Dual-energy X-ray absorptiometry (DXA) was used as the reference standard to measure bone mineral density (BMD) at the lumbar spine and total hip using a Lunar Prodigy Advance densitometer (GE Healthcare, Madison, WI, USA). BMD was expressed in grams per square centimeter (g/cm²) and reported as T-scores. Participants with T-scores ≤ − 2.0 were classified as having low BMD, considering both the lumbar spine and total hip regions, separately and combined. Given the requirement for a dichotomous cutoff point in accuracy studies, this T-score threshold was selected because it represents the transition from low to moderate fracture risk in women aged 50 years without additional risk factors39. Moreover, this cutoff value has been used in previous diagnostic accuracy studies assessing low BMD12,40,41. The densitometer was calibrated daily before data collection to ensure consistent measurement conditions across participants. All assessments were performed by the same trained professional experienced in DXA-based BMD evaluation. The countermovement jump (CMJ) was used as the index test and was performed on a force plate (BIOMEC400, EMG System, São José dos Campos, Brazil). The force plate was embedded within a larger elevated platform (3 × 3 m), flush with the surrounding surface, so that no step or edge was present around the force plate. Ground reaction force signals were collected at a sampling rate of 1000 Hz and processed using compiled MATLAB routines provided within the force plate’s proprietary software (MathWorks, Natick, MA, USA). The parameters calculated included jump height (cm), peak force (N), and peak power (W). Jump height was derived from flight time, as this method is compatible with low-cost field-based instruments, including contact mats, photoelectric cells, and smartphone applications, thereby enhancing the translational potential of this variable for broader clinical and community use. Before testing, the evaluator explained the procedures in detail, and participants completed a familiarization period during which they performed five submaximal CMJs as a warm-up. Throughout testing, a trained evaluator was positioned immediately behind each participant to provide physical assistance if needed. Subsequently, three maximal CMJs were performed, with one-minute rest intervals between trials. Throughout the test, participants kept their hands on their hips and wore their usual athletic footwear. Participants were instructed to perform a semi-squat to approximately 110° of internal knee angle prior to jumping, as this depth has been shown to maximize power output during the CMJ42. Trials in which the participant visibly failed to reach the required knee flexion depth, lost balance, or did not maintain hands on hips were discarded and repeated. For analysis, only the highest value for each variable was retained. All CMJ variables, including peak force and peak power, were analyzed in absolute terms. All assessments were conducted in the afternoon (14:00–17:00 h) in a temperature-controlled environment (22 °C). Participants were instructed to have a light meal at least two hours before testing, to avoid vigorous physical activity in the 24 h preceding the session, and to maintain their habitual diet during the testing period. To assess test–retest reliability, 10% of the sample was randomly selected and reassessed after a 7-day interval under identical testing conditions. Intraclass correlation coefficients (ICC, two-way mixed-effects model, absolute agreement) and 95% confidence intervals (95% CI) were calculated for all primary variables. Reliability was excellent for lumbar spine BMD (ICC = 0.978; 95% CI: 0.929–0.993) and total hip BMD (ICC = 0.990; 95% CI: 0.969–0.997). CMJ-derived variables also demonstrated high reliability: jump height (ICC = 0.891; 95% CI: 0.692–0.965), peak force (ICC = 0.911; 95% CI: 0.737–0.972), and peak power (ICC = 0.874; 95% CI: 0.648–0.959). Statistical analysis Data normality was assessed using the Kolmogorov–Smirnov test. Differences between postmenopausal women with normal and low BMD were analyzed using Student’s t-test. The ability of CMJ-derived variables to discriminate low BMD was examined using receiver operating characteristic (ROC) curve analysis, with 95% confidence intervals (CIs). Accuracy, expressed as the area under the curve (AUC), was classified as low (0.50–0.69), moderate (0.70–0.89), or high (≥ 0.90)43. Optimal cutoff points for each variable were determined using the Youden index (sensitivity + specificity − 1). For variables showing at least moderate discriminatory accuracy (AUC ≥ 0.70), positive and negative likelihood ratios were calculated. Associations between BMD status and CMJ performance were examined using binary logistic regression models, with results expressed as crude and adjusted odds ratios (ORs). Due to conceptual overlap between age and years since menopause, both variables were retained in the adjusted models as key indicators of menopausal and aging-related effects. Data analyses were conducted using SPSS version 25.0 (IBM Corp., Chicago, IL, USA), except for ROC curve procedures, which were performed in MedCalc version 23.2 (Acacialaan, Ostend, Belgium). Statistical significance was set at p < 0.05. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Acknowledgements The authors thank the State Secretariat for Science, Technology and Higher Education – SETI – FUNDO PARANÁ, Brazil for acquiring the bone densitometer used in this study. Abbreviations Area under the curve Bone mineral density Countermovement jump Dual-energy X-ray absorptiometry Odds ratio Receiver operating characteristic Author contributions R.G.O. and L.C.O. participated in the design of the study and drafted the manuscript. M.M.S. and L.V.B. provided assistance for data acquisition and analysis. R.G.O. and A.F.A. conceived of the study and performed manuscript review. All authors read and approved the final manuscript. Data availability The dataset supporting the conclusions of this article is available in the Zenodo repository, https://doi.org/10.5281/zenodo.19067546. Declarations Competing interests The authors declare no competing interests. Ethics approval and consent to participate This study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Research Ethics Committee for Human Subjects at the Universidade Estadual do Norte do Paraná (opinion 3,493,411). Written informed consent was obtained from all individual participants included in the study. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement The dataset supporting the conclusions of this article is available in the Zenodo repository, https://doi.org/10.5281/zenodo.19067546.